Streetbeat News

Regulatory

TSLA

The U.S. Securities and Exchange Commission (SEC) has filed a lawsuit against Tesla Inc's CEO, Elon Musk, seeking his testimony over his 2022 Twitter purchase. The SEC launched an investigation to determine if securities fraud was committed during Musk's Twitter takeover. Musk reportedly bought Twitter shares before taking it private in a $44 billion deal. The SEC has tried to meet with Musk multiple times, but he has refused, citing various reasons including harassment.

Portfolio Pulse from Adam Eckert

October 05, 2023 | 9:03 pm

SFE

Safeguard Scientifics' board has approved a plan to voluntarily terminate the registration of its common stock with the SEC and voluntarily delist from Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 9:01 pm

AORT

Artivion has announced the presentation of real-world data from a post-market study of On-X Aortic Heart Valve Replacement patients treated with low dose Warfarin. The data was presented at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 8:53 pm

CLRB

Cellectar Biosciences Inc has filed for a shelf of up to 34.5 million shares of common stock by selling stockholders, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 8:50 pm

REGN

Regeneron Pharmaceuticals expects its Q3 financial results to include an acquired In-Process Research and Development (IPR&D) charge of $100M on a pre-tax basis, according to a recent filing.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 8:27 pm

NAVB

The NYSE American has announced that it will suspend trading in Navidea Biopharmaceuticals (NAVB).

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 8:22 pm

JNPR

Juniper Networks has approved a restructuring plan aimed at reallocating resources to better support its strategic priorities, according to a filing.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 8:14 pm

CSCO

Cisco has announced changes to its product categories and customer markets to simplify reporting to investors and stakeholders. The revised product categories and customer markets will be used in the Q1 FY 2024 conference call scheduled for Wednesday, November 15, 2023.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 8:12 pm

CATX

Perspective Therapeutics (NYSE:CATX) announced that long-term data regarding Cesium-131 brachytherapy in the treatment of prostate cancer, as well as preliminary long-term data of Cesium-131 utilized in salvage treatment of recurrent cervical and uterine cancers were presented at the American Society for Radiation Oncology's (ASTRO) Annual Conference. The company is the world's only producer of Cesium-131 seeds for brachytherapy which provide expanding internal radiation treatment options for various types of cancer.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 8:12 pm

TSLA

TWTR

The U.S. Securities and Exchange Commission (SEC) is investigating Elon Musk's recent purchases of Twitter stock, according to a court filing cited by Reuters.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 8:11 pm